Feb 04, 2020 - Teva (TEVA) posts positive results from two phase II/III studies on Ajovy for treating patients with chronic and episodic migraine in Japan.
Feb 05, 2020 - The following slide deck was published by MELEXIS NV IEPER in conjunction with their 2019 Q4 earnings call.
Feb 05, 2020 - NVS earnings call for the period ending December 31, 2019.
Feb 07, 2020 - Alnylam (ALNY) posts a wider-than-expected loss, while revenues beat estimates marginally in the fourth quarter of 2019.
Feb 10, 2020 - Regeneron (REGN) announces positive two-year results from the phase III PANORAMA study on lead ophthalmology drug, Eylea.
Feb 11, 2020 - The FDA accepts Gilead's (GILD) BLA for its second CAR T cell therapy, KTE-X19.
Feb 13, 2020 - The following slide deck was published by Arcadis NV in conjunction with their 2019 Q4 earnings call.
Feb 14, 2020 - Arcadis NV (OTCPK:ARCVF) Q4 2019 Earnings Conference Call February 13, 2020 4:00 AM ET Company Participants Jurgen Pullens - Director of Investor Relations Peter Oosterveer - Chief Executive Officer S
Feb 14, 2020 - Telenet Group Holding NV (OTCPK:TLGHF) Q4 2019 Results Conference Call February 12, 2020 09:00 AM ET Company Participants Rob Goyens - Investor Relations John Porter - Chief Executive Officer Erik den
Feb 14, 2020 - Yandex NV (NASDAQ:YNDX) Q4 2019 Earnings Conference Call February 14, 2020, 08:00 ET Company Participants Katya Zhukova - IR Director Tigran Khudaverdyan - Deputy CEO & Director Gregory Abovsky -